Evidence map›Paper›PMID 22952805›Full record

ArticlePloS one2012

Genome-wide association study of African and European Americans implicates multiple shared and ethnic specific loci in sarcoidosis susceptibility.

Indra Adrianto, Chee Paul Lin, Jessica J Hale, Albert M Levin, Indrani Datta, Ryan Parker, Adam Adler, Jennifer A Kelly, Kenneth M Kaufman, Christopher J Lessard and 6 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 64 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed, 2 pooled it
7.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

64 citing papers in PubMed, 2 syntheses or guidelines pooled it, 122 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Sarcoidosis extent relates to molecular variability.Clinical and experimental immunology · 2017
    Trial
  4. Trial
  5. [Clinical features and prognosis of sarcoidosis with ocular lesions as the initial manifestation].Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences · 2025
    Article
  6. Review
  7. Article
  8. Inclusivity in Research Matters: Variants inAmerican journal of respiratory and critical care medicine · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Genetics of neurosarcoidosis.Journal of neuroimmunology · 2022
    Review
  16. Article
  17. Progress in the genetics of uveitis.Genes and immunity · 2022
    Review
  18. Article
  19. Offense and Defense in Granulomatous Inflammation Disease.Frontiers in cellular and infection microbiology · 2022
    Review
  20. Epigenetics and sarcoidosis.European respiratory review : an official journal of the European Respiratory Society · 2021
    Review

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

16 authors at 7 institutions in 1 country.

Indra AdriantoArthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, United States of America.
Chee Paul Lin
Jessica J Hale
Albert M Levin
Indrani Datta
Ryan Parker
Adam Adler
Jennifer A Kelly
Kenneth M Kaufman
Christopher J Lessard
Kathy L Moser
Robert P Kimberly
John B Harley
Michael C Iannuzzi
Benjamin A Rybicki
Courtney G Montgomery
Oklahoma Medical Research Foundation · USCincinnati Children's Hospital Medical Center · USHenry Ford Health System · USUniversity of Oklahoma Health Sciences Center · USMichigan United · USSUNY Upstate Medical University · USUniversity of Alabama at Birmingham · US

Funding

Targeting the p53 pathway for reversal of oral premalignancyP50CA097007 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI MYERS, JEFFREY NICHOLAS · 2002 to 2012
$26.1M
UT M.D. Anderson Cancer Center SPORE in MelanomaP50CA093459 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI GRIMM, ELIZABETH A · 2004 to 2014
$23.7M
VALIDATING NOVEL GENES IMPLICATED IN LEUKOCYTE CHEMOTAXISP20RR020143 · NCRR · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI GAFFNEY, PATRICK M · 2004 to 2011
$21.0M
Program Project in the Genetics of SLEP01AR049084 · NIAMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI KIMBERLY, ROBERT P. · 2002 to 2012
$12.7M
SequencingP01AI083194 · NIAID · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI KIMBERLY, ROBERT P. · 2009 to 2013
$9.6M
GENE MAPPING IN WOMEN WITH SYSTEMIC LUPUS ERYTHEMATOSUSR01AR043274 · NIAMS · UNIVERSITY OF MINNESOTA TWIN CITIES · PI SIVILS, KATHY L. · 1996 to 2010
$6.5M
SARCOIDOSIS GENETIC LINKAGE CONSORTIUMU01HL060263 · NHLBI · HENRY FORD HEALTH SYSTEM · PI IANNUZZI, MICHAEL C · 1999 to 2003
$6.5M
Molecular Epidemiology of Head and Neck CancerR01ES011740 · NIEHS · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI WEI, QINGYI · 2001 to 2012
$6.3M
GENETIC ASSOCIATION WITH LUPUS IN AMERICAN BLACKSR01AR042460 · NIAMS · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI HARLEY, JOHN BARKER · 1993 to 2009
$5.1M
Genetic Linkage in LupusR37AI024717 · NIAID · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI HARLEY, JOHN BARKER · 2005 to 2014
$4.2M
Admixture Mapping of Sarcoidosis Genes in African AmericanR01HL092576 · NHLBI · HENRY FORD HEALTH SYSTEM · PI RYBICKI, BENJAMIN A. · 2008 to 2011
$2.9M
African American Sarcoidosis Genetics ResourceRC2HL101499 · NHLBI · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI MONTGOMERY, COURTNEY · 2009 to 2010
$2.0M
NCI NIH HHS 3P50CA093459NCI NIH HHS 5P50CA097007NCI NIH HHS 5R01CA133996NCRR NIH HHS P20 RR020143NCRR NIH HHS P20-RR020143NHGRI NIH HHS HHSN268200782096CNHLBI NIH HHS 1RC2HL101499NHLBI NIH HHS R01 HL092576NHLBI NIH HHS R01-HL092576NHLBI NIH HHS R01-HL54306NHLBI NIH HHS RC2 HL101499NHLBI NIH HHS U01 HL060263NHLBI NIH HHS U01-HL060263NIAID NIH HHS P01 AI083194NIAID NIH HHS P01-AI083194NIAID NIH HHS R37 AI024717NIAID NIH HHS R37-AI024717NIAID NIH HHS R56 AI072727NIAID NIH HHS R56-AI072727NIAMS NIH HHS N01 AR062277NIAMS NIH HHS N01-AR62277NIAMS NIH HHS P01 AR049084NIAMS NIH HHS P01-AR049084NIAMS NIH HHS R01 AR042460NIAMS NIH HHS R01-AR042460NIAMS NIH HHS R01 AR043274NIAMS NIH HHS R01-AR043274NIEHS NIH HHS 5R01ES011740
6 · The paper itself

Abstract

Sarcoidosis is a systemic inflammatory disease characterized by the formation of granulomas in affected organs. Genome-wide association studies (GWASs) of this disease have been conducted only in European population. We present the first sarcoidosis GWAS in African Americans (AAs, 818 cases and 1,088 related controls) followed by replication in independent sets of AAs (455 cases and 557 controls) and European Americans (EAs, 442 cases and 2,284 controls). We evaluated >6 million SNPs either genotyped using the Illumina Omni1-Quad array or imputed from the 1000 Genomes Project data. We identified a novel sarcoidosis-associated locus, NOTCH4, that reached genome-wide significance in the combined AA samples (rs715299, P(AA-meta) = 6.51 × 10(-10)) and demonstrated the independence of this locus from others in the MHC region in the same sample. We replicated previous European GWAS associations within HLA-DRA, HLA-DRB5, HLA-DRB1, BTNL2, and ANXA11 in both our AA and EA datasets. We also confirmed significant associations to the previously reported HLA-C and HLA-B regions in the EA but not AA samples. We further identified suggestive associations with several other genes previously reported in lung or inflammatory diseases.

Indexed as

Genome-Wide Association StudyBlack or African AmericanDatabases, GeneticFemaleGenetic LociGenetic Predisposition to DiseaseHumansMajor Histocompatibility ComplexMaleMeta-Analysis as TopicPedigreeReproducibility of ResultsSarcoidosisWhite People

Identifiers

PMID22952805
PMCPMC3428296
OpenAlexW2029857463

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.